Jane Street Group, LLC Invitae Corp Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$6.28 - $15.59 $432,064 - $1.07 Million	-68,800 Reduced 20.4%	268,500 $2.14 Million
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $1.25 Million - $2.44 Million	-85,100 Reduced 20.15%	337,300 $5.15 Million
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $2.33 Million - $3.22 Million	95,800 Added 29.33%	422,400 $12 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $6.4 Million - $9.91 Million	-245,200 Reduced 42.88%	326,600 $11 Million
Q1 2021 May 18, 2021	BUY	$33.06 - $56.93 $7.05 Million - $12.1 Million	213,300 Added 59.5%	571,800 $21.8 Million

Q4 2020 Feb 17, 2021	BUY	$39.09 - $57.4 $6.59 Million - $9.68 Million	168,600 Added 88.78%	358,500 $15 Million
Q3 2020 Nov 17, 2020	BUY	$28.43 - $44.67 $2.5 Million - $3.93 Million	87,900 Added 86.18%	189,900 $8.23 Million
Q2 2020 Aug 17, 2020	BUY	$11.71 - $30.29 $468,400 - $1.21 Million	40,000 Added 64.52%	102,000 $3.09 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $343,800 - $1.24 Million	45,000 Added 264.71%	62,000 $848,000
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $255,340 - $349,690	17,000 New	17,000 $274,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.